Age (years) | 67 (41 - 83) |
Male | 17 (94%) |
Culprit coronary artery | |
LAD | 8 (44%) |
LCx | 1 (6%) |
RCA | 9 (50%) |
TIMI grade 0 flow before pPCI | 18 (100%) |
TIMI grade 3 flow after pPCI | 18 (100%) |
Duration of ischemia (min) | 158 (60 - 387) |
MaR (% of left ventricle by MPS) | 23 (5 - 48) |
Infarct size (% of left ventricle) | 7 (0 - 21) |
Relative infarct size (% of MaR by MPS) | 22 (0 - 54) |
Previous angina pectoris | 2 (11%) |
Former smoker | 9 (50%) |
Active smoker | 6 (33%) |
ACE inhibitor | 1 (6%) |
Acetyl salicylic acid | 2 (11%) |
Angiotensin-II receptor blocker | 1 (6%) |
Beta blocker | 0 (0%) |
Calcium channel blocker | 1 (6%) |
Diuretic | 2 (11%) |
Statin | 1 (6%) |
Oral anti-diabetic | 1 (6%) |
Insulin | 3 (17%) |